Sign up to save your podcasts
Or
Share JAMA Ophthalmology : Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab for CRVO
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
JAMA Ophthalmology : Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab for CRVO
Interview with Ian Leslie. Mcallister, FRANZCO, author of Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab Monotherapy for Central Retinal Vein Occlusion: A Randomized Clinical Trial
View all episodes
By The JAMA Network
4.9
1212 ratings
Interview with Ian Leslie. Mcallister, FRANZCO, author of Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab Monotherapy for Central Retinal Vein Occlusion: A Randomized Clinical Trial
More shows like JAMA Network
View all
JAMA Editors' Summary
135 Listeners
NEJM This Week
320 Listeners
AFP: American Family Physician Podcast
696 Listeners
JAMA Clinical Reviews
495 Listeners
Medicine and Science from The BMJ
37 Listeners
Diabetes Core Update
101 Listeners
Mayo Clinic Talks
291 Listeners
The Curbsiders Internal Medicine Podcast
3,330 Listeners
JAMA Pediatrics Editors' Summary
38 Listeners
JAMA Neurology Author Interviews
13 Listeners
JAMA Dermatology Author Interviews
16 Listeners
JAMA Internal Medicine Author Interviews
18 Listeners
JAMA Otolaryngology–Head Neck Surgery Author Interviews
6 Listeners
Core IM | Internal Medicine Podcast
1,152 Listeners
JAMAevidence The Rational Clinical Examination
30 Listeners
Annals On Call Podcast
196 Listeners
JAMA Medical News
89 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
363 Listeners
Cardionerds: A Cardiology Podcast
430 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
19 Listeners
The Curious Clinicians
369 Listeners
NEJM AI Grand Rounds
58 Listeners